Speeding ticket10 Jan 2019 12:35
Diurnal Group plc (AIM: DNL), the specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases, notes the recent movement in its share price and, notwithstanding the Company's announcement this morning regarding a patent grant, the Company confirms that it is not aware of any specific reason for this movement.